US Stock MarketDetailed Quotes
IBO Impact BioMedical
- 2.990
- +0.480+19.12%
Close Nov 15 16:00 ET
- 2.990
- +0.000+0.00%
Post 20:01 ET
34.40MMarket Cap29.60P/E (TTM)
2.990High2.530Low79.06KVolume2.540Open2.510Pre Close225.97KTurnover5.27%Turnover RatioLossP/E (Static)11.50MShares3.20052wk High1.10P/B4.48MFloat Cap1.22052wk Low--Dividend TTM1.50MShs Float3.200Historical High--Div YieldTTM18.33%Amplitude1.220Historical Low2.858Avg Price1Lot Size
Impact BioMedical Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00%50K | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | 0.00%50K | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 4.55%1.13M | -37.90%626K | -3.99%771K | 16.62%4.03M | 10.37%1.14M | 21.26%1.08M | 26.00%1.01M | 13.26%803K | 0.00%3.45M | -23.16%1.03M |
| Selling and administrative expenses | 65.29%719K | -26.86%335K | 28.78%434K | 50.62%1.58M | 194.61%601K | 59.34%435K | 59.58%458K | 35.34%337K | 0.00%1.05M | -54.67%204K |
| -Selling and marketing expense | 2,611.76%461K | 80.00%18K | -52.94%8K | ---- | ---- | --17K | --10K | --17K | ---- | ---- |
| -General and administrative expense | -38.28%258K | -29.24%317K | 33.13%426K | 50.62%1.58M | 216.18%645K | 53.11%418K | 56.10%448K | 28.51%320K | 0.00%1.05M | -54.67%204K |
| Research and development costs | -77.03%82K | --0 | -72.07%50K | -6.44%1.15M | -82.38%92K | 8.18%357K | 29.13%266K | 6.55%179K | 0.00%1.23M | -10.15%522K |
| Depreciation amortization depletion | 0.36%281K | -0.36%279K | 0.00%280K | 0.63%1.12M | 0.72%280K | 0.36%280K | 0.72%280K | 0.72%280K | 0.00%1.11M | 0.00%278K |
| -Depreciation and amortization | 0.36%281K | -0.36%279K | 0.00%280K | 0.63%1.12M | 0.72%280K | 0.36%280K | 0.72%280K | 0.72%280K | 0.00%1.11M | 0.00%278K |
| Other operating expenses | 650.00%45K | 200.00%12K | 0.00%7K | 170.59%184K | 492.86%166K | -14.29%6K | -86.21%4K | -50.00%7K | 0.00%68K | -17.65%28K |
| Operating profit | -4.55%-1.13M | 37.90%-626K | 3.99%-771K | -18.33%-4.03M | -10.37%-1.14M | -21.26%-1.08M | -34.40%-1.01M | -13.26%-803K | 0.00%-3.4M | 20.19%-1.03M |
| Net non-operating interest income expense | -205.05%-302K | -128.32%-258K | -131.63%-227K | 1.60%-431K | 31.84%-122K | -11.24%-99K | -130.61%-113K | -164.86%-98K | 0.00%-438K | 47.81%-179K |
| Non-operating interest income | 0.00%3K | 0.00%3K | 0.00%3K | -45.83%13K | 103.75%3K | 0.00%3K | -96.67%3K | -96.88%3K | 0.00%24K | -35.59%-80K |
| Non-operating interest expense | 199.02%305K | 125.00%261K | 127.72%230K | -3.90%444K | 26.26%125K | 10.87%102K | -16.55%116K | -24.06%101K | 0.00%462K | -65.14%99K |
| Other net income (expense) | 5.67M | 101.29%52K | 0 | 52K | 0.00%-4.03M | |||||
| Gain on sale of security | --5.67M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special income (charges) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 0.00%-4.1M | ---- |
| -Write off | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 0.00%4.1M | ---- |
| Other non- operating income (expenses) | ---- | ---- | ---- | -21.21%52K | --0 | ---- | ---- | --52K | 0.00%66K | ---- |
| Income before tax | 460.32%4.24M | 21.14%-884K | -17.55%-998K | 44.05%-4.41M | 75.96%-1.26M | -20.35%-1.18M | -40.30%-1.12M | -13.81%-849K | 0.00%-7.88M | 8.70%-5.25M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00%-621K | -378.12%-1.88M |
| Net income | 460.32%4.24M | 21.14%-884K | -17.55%-998K | 39.26%-4.41M | 62.54%-1.26M | 47.36%-1.18M | -40.30%-1.12M | -13.81%-849K | 0.00%-7.26M | 37.11%-3.37M |
| Net income continuous Operations | 460.32%4.24M | 21.14%-884K | -17.55%-998K | 39.26%-4.41M | 62.54%-1.26M | 47.36%-1.18M | -40.30%-1.12M | -13.81%-849K | 0.00%-7.26M | 37.11%-3.37M |
| Minority interest income | 60.00%-6K | 126.32%5K | 81.25%-36K | 65.20%-71K | -550.00%-26K | 77.61%-15K | 71.64%-19K | -149.35%-192K | 0.00%-204K | -105.13%-4K |
| Net income attributable to the parent company | 465.49%4.25M | 19.33%-889K | -46.42%-962K | 38.51%-4.34M | 63.27%-1.24M | 46.43%-1.16M | -50.55%-1.1M | 1.79%-657K | 0.00%-7.05M | 38.08%-3.36M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 465.49%4.25M | 19.33%-889K | -46.42%-962K | 38.51%-4.34M | 63.27%-1.24M | 46.43%-1.16M | -50.55%-1.1M | 1.79%-657K | 0.00%-7.05M | 38.08%-3.36M |
| Basic earnings per share | 466.10%0.37 | 19.33%-0.0773 | -46.42%-0.0837 | 38.51%-0.3771 | 63.27%-0.1074 | 46.43%-0.1011 | -50.55%-0.0958 | 1.81%-0.0571 | 0.00%-0.6133 | 38.08%-0.2924 |
| Diluted earnings per share | 159.37%0.06 | 19.33%-0.0773 | -46.42%-0.0837 | 38.51%-0.3771 | 63.27%-0.1074 | 46.43%-0.1011 | -50.55%-0.0958 | 1.81%-0.0571 | 0.00%-0.6133 | 38.08%-0.2924 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
